About Shanghai Oriental Hospital
Clinical Trials at Shanghai Oriental Hospital
During the past decade, Shanghai Oriental Hospital conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Shanghai Oriental Hospital" #1 sponsor was "Shanghai Miracogen Inc." with 3 trials, followed by "Sichuan Baili Pharmaceutical Co., Ltd." with 2 trials
sponsored, "Zensun Sci. & Tech. Co., Ltd." with 2 trials sponsored, "BeiJing Yijiayi Medicine Techonoloy Co., Ltd." with 1 trials sponsored and "Bio-Thera Solutions"
with 1 trials sponsored. Other sponsors include -2 different institutions and
companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Shanghai Oriental Hospital"
#1 collaborator was "Dalian Holley Kingkong Pharmaceutical Co., Ltd" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Shanghai Oriental Hospital
According to Clinical.Site data, the most researched conditions in "Shanghai Oriental Hospital" are
"Advanced Solid Tumor" (2 trials), "Head and Neck Squamous Cell Carcinoma" (2 trials), "Advanced Malignant Solid Tumors" (1 trials), "Advanced Primary Liver Cancer" (1 trials) and "C-Met Mutation-Related Tumors" (1 trials). Many other conditions were trialed in "Shanghai Oriental Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Shanghai Oriental Hospital
Most popular intervention types in "Shanghai Oriental Hospital" are "Drug" (12 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "MRG002" (2 trials), "Placebo" (2 trials), "SI-B001" (2 trials), "BAT6005 injection" (1 trials) and "Elemene" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Shanghai Oriental Hospital
The vast majority of trials in "Shanghai Oriental Hospital" are
12 trials for "All" genders.
Clinical Trials Status at Shanghai Oriental Hospital
Currently, there are NaN active trials in "Shanghai Oriental Hospital".
undefined are not yet recruiting,
9 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Shanghai Oriental Hospital,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Shanghai Oriental Hospital, 6 "Phase 1"
clinical trials were conducted, 7 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".